6-(2-ジエチルアミノエトキシ)-N,N-ジメチルベンゾチアゾール-2-アミン 化学特性,用途語,生産方法
世界保健機関（WHO）
Dimazole, an antifungal agent, was introduced in 1951 for the
treatment of tinea infections. Although the major manufacturer subsequently
discontinued marketing preparations in the United States, the US Food and Drug
Administration formally withdrew marketing approval for such preparations in 1977
on the grounds of their association with severe neurotoxic reactions, their
potential for misuse and the availability of safer alternative products. Topical
preparations of dimazole remain available in some 40 countries.
6-(2-ジエチルアミノエトキシ)-N,N-ジメチルベンゾチアゾール-2-アミン 上流と下流の製品情報
原材料
準備製品